Investing Profile
Michael Anstey
Your Intro Paths to Michael Anstey
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Michael is a member of
Boston Consulting Group (BCG) Network
288 CONNECTIONS
University of Oxford Network
267 CONNECTIONS
Queen's University Network
58 CONNECTIONS
Find Michael Anstey on
cbCurrent Investing Position
Cambridge Innovation Capital Partner
Investment Range
$600K - $6.0M
Sweet Spot
$3.3M
Investments On Record
4
Current Fund Size
£225M
Michael Anstey is on these Sector & Stage Rankings
Michael Anstey's Investments On Record (3)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
TRIMTECH Therapeutics | SeedJun 2026$14M SeedMar 2025$31M | $45M |
Immutrin | Series AMar 2026$87M | $87M |
PredictImmune | Series BJul 2019$12M | $25M |
Michael Anstey's Media (1)
Michael Anstey's Experience
Investment Analyst Oxford CapitalPresent
Principal Boston Consulting Group (BCG)Present
Board Member Bicycle TherapeuticsPresent
Board Member STORM Therapeutics LimitedPresent
Board Member CongenicaPresent
Board Member Proteorex Therapeutics Inc.Present
Board Member EpitopeaPresent
Board Member Innovate CambridgePresent
Board Member ImmutrinPresent
Board Observer NucleraPresent
Member Board of Directors TRIMTECH Therapeutics LimitedPresent
Co-Founder Proteorex Therapeutics Inc.Present
Partner Cambridge Innovation CapitalPresent
Michael Anstey's Education
Queen's University First Class BSc(Hons) Biology
University of Oxford DPhil Department of Zoology
Investors who invest with Michael Anstey
Founders who looked at Michael Anstey's profile also looked at these Scouts & Angels